Prof Ana Alfirevic MD, PhD

Professor Molecular and Clinical Pharmacology

    Research

    Research Group Membership
    Research Grants

    The role of transporters in the uptake of AV-101

    VISTAGEN THERAPEUTICS, INC (USA)

    September 2017 - June 2021

    Systems pharmacology approaches to drug-induced hypersensitivity reactions

    MALAYSIAN GOVERNMENT (MALAYSIA)

    March 2015 - February 2018

    PREDICTION-ADR: Personalisation of tREatment In Cardiovascular disease through next generation sequencing in Adverse Drug Reactions

    EUROPEAN COMMISSION

    September 2013 - February 2017

    Genetic markers for carbamazepine-induced hypersensitivty syndrome

    EPILEPSY RESEARCH UK (UK)

    June 2012 - November 2013

    A pharmacogenomic approach to coumarin anticoagulant therapy (PACT)

    EUROPEAN COMMISSION

    October 2008 - March 2013

    EURIPIDES - EUropean Research initiative to develop Imaging Probes for early In-vivo Diagnosis and Evaluation of response to therapeutic Substances

    EUROPEAN COMMISSION

    February 2008 - January 2013

    Pharmacogenetics of Methadone response

    NATIONAL HEALTH AND MEDICAL RESEARCH COUNCIL (AUSTRALIA)

    September 2010 - February 2013

    Research Collaborations

    JC Smith

    External: AstraZeneca Pharmceuticals

    1)The role of HSP70 gene cluster polymorphisms in carbamazepine induced hypersensitivity reactions
    2) Genetic polymorphisms and tacrine induced hepatotoxicity